Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Actuate Therapeutics, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Daniel M. Schmitt: trading record in brief
Daniel M. Schmitt is a declared insider of Actuate Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 13 February 2026 and the latest from 14 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 14 August 2026: an option exercise, in Actuate Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel M. Schmitt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
272,056 shares0Common StockSEC:0001683168-26-006493:0
120,521 shares@ US$1.01Common StockSEC:0001683168-26-006493:1
272,055 shares0Common StockSEC:0001683168-26-001039:0
3 of 3 declarations
